← back to search

Neng Wang

Suizhou Central Hospital · CN
Area of research
Immunology · Cell Biology
Research interest
Research interests include Immune cells in cancer, Caveolin-1 and cellular processes, Autophagy in Disease and Therapy, and Cancer Cells and Metastasis.
h-index
45
citations
7,645
works
198
NIH funding
primary concept
email

Recent publications

Chronic Psychological Stress Activates TRP/TAM/CXCL1 Signaling to Promote Breast Cancer Adipocyte Lipolysis via KEAP1 m <sup>6</sup> A Demethylation
Research 2025cited by 2position: middledoi
The chemosensitizing activity of betulinic acid in suppressing macrophage polarization through GSK-3β/β-catenin/CXCL1 signaling in breast cancer
Phytomedicine 2025cited by 1position: lastdoi
The chemosensitizing activity of betulinic acid in suppressing macrophage polarization through GSK-3β/β-catenin/CXCL1 signaling in breast cancer
Phytomedicine 2025cited by 1position: contributordoi
Tumor-associated macrophages/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R/STAT3/HMGB1 signaling
Cell Death and Disease 2024cited by 34position: middledoi
Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling
Journal of Experimental & Clinical Cancer Research 2024cited by 26position: middledoi
Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment
Chinese Journal of Natural Medicines 2024cited by 10position: middledoi
XIAOPI formula inhibits chemoresistance and metastasis of triple-negative breast cancer by suppressing extracellular vesicle/CXCL1-induced TAM/PD-L1 signaling
Phytomedicine 2024cited by 9position: middledoi
Riboflavin alleviates the occurrence of anthracnose caused by Colletotrichum gloeosporioides in postharvest mango and the possible mechanisms involved
Food Bioscience 2024cited by 8position: middledoi
Developing liver-targeted naringenin nanoparticles for breast cancer endocrine therapy by promoting estrogen metabolism
Journal of Nanobiotechnology 2024cited by 8position: middledoi
Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial
Breast Cancer Targets and Therapy 2024cited by 1position: middledoi
Chronic psychological stress promotes breast cancer pre-metastatic niche formation by mobilizing splenic MDSCs via TAM/CXCL1 signaling
Journal of Experimental & Clinical Cancer Research 2023cited by 65position: middledoi
Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM/CCL5-mediated osteoclastogenesis
Phytomedicine 2023cited by 38position: middledoi
Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment
International Journal of Nanomedicine 2023cited by 36position: middledoi
Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer
Frontiers in Oncology 2023cited by 16position: middledoi
Cefoselis enhances breast cancer chemosensitivity by directly targeting GRP78/LRP5 signalling of cancer stem cells
Clinical and Translational Medicine 2023cited by 5position: middledoi
Dying cell-released exosomal CXCL1 promotes breast cancer metastasis by activating TAM/PD-L1 signaling
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 0position: middledoi
Editorial: Local and traditional medicine in regulation of the cancer immune suppression microenvironment, Volume II
Frontiers in Pharmacology 2023cited by 0position: middledoi
Dietary Compound Diosmetin Chemosensitizes Breast Cancer Stem Cells by Suppressing HMGB1-mediated Autophagy
BIO Web of Conferences 2023cited by 0position: firstdoi
Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway
Journal of Advanced Research 2022cited by 51position: middledoi
A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer
Frontiers in Oncology 2022cited by 14position: lastdoi
Development and Validation of a Risk Prediction Model for Breast Cancer Prognosis Based on Depression-Related Genes
Frontiers in Oncology 2022cited by 12position: middledoi
Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis
Frontiers in Pharmacology 2022cited by 3position: lastdoi
Corrigendum: Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling
Frontiers in Pharmacology 2022cited by 1position: firstdoi
Corrigendum to “XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy” [Biomed. Pharmacother. 120 (2019) 109519]
Biomedicine & Pharmacotherapy 2022cited by 0position: firstdoi
Correction to: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells
Journal of Experimental & Clinical Cancer Research 2022cited by 0position: firstdoi
Corrigendum to: “Network-pharmacology-based identification of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis” [Biomed. Pharmacother. 112 (2019) 108607]
Biomedicine & Pharmacotherapy 2022cited by 0position: middledoi
Research trends in pharmacological modulation of tumor‐associated macrophages
Clinical and Translational Medicine 2021cited by 105position: firstdoi
Research trends in pharmacological modulation of tumor-associated macrophages.
2021cited by 88position: contributordoi
Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration
Cell Communication and Signaling 2021cited by 78position: middledoi
Ursolic Acid Inhibits Breast Cancer Metastasis by Suppressing Glycolytic Metabolism via Activating SP1/Caveolin-1 Signaling
Frontiers in Oncology 2021cited by 56position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhiyu Wang · Guangzhou University of Chinese Medicine65 papers (2012–2025)Shengqi Wang · Guangzhou University of Chinese Medicine52 papers (2017–2025)Yifeng Zheng · Guangzhou University of Chinese Medicine49 papers (2017–2025)Fengxue Zhang · Guangzhou University of Chinese Medicine21 papers (2017–2022)Bowen Yang · Guangzhou University of Chinese Medicine16 papers (2018–2024)Bowen Yang · Northeast Agricultural University16 papers (2018–2024)Bo Pan · Guangzhou University of Chinese Medicine16 papers (2021–2024)Xuan Wang · Sun Yat-sen University Cancer Center16 papers (2020–2024)Yi Lin · Guangzhou University of Chinese Medicine14 papers (2014–2022)Juping Zhang · Taiyuan University of Technology14 papers (2019–2025)Honglin Situ · Guangzhou University of Chinese Medicine13 papers (2014–2024)Juping Zhang · Guangzhou University of Chinese Medicine12 papers (2020–2024)Pengxi Liu · Guangzhou University of Chinese Medicine9 papers (2014–2020)Cheng Peng · Pennsylvania State University8 papers (2014–2022)Bowen Yang · Guangzhou University of Chinese Medicine8 papers (2019–2024)Min Li · China Agricultural University8 papers (2018–2022)Xiaoming Xie · Nanchang University7 papers (2015–2022)Hailin Tang · Sun Yat-sen University7 papers (2015–2022)Jiangang Shen · Guangzhou University of Chinese Medicine6 papers (2012–2015)Jianping Chen · Guangzhou University of Chinese Medicine5 papers (2012–2017)